Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grifols Pref | Madrid | Healthcare | Pharmaceuticals | €6.80B | 43.6x | 0.01 | €8.01 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.6% Upside | Upgrade to Pro+ | |
Grifols | Madrid | Healthcare | Pharmaceuticals | €6.80B | 43.7x | 0.01 | €10.01 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laborat.Rovi | Madrid | Healthcare | Pharmaceuticals | €3.67B | 25.3x | -1.37 | €71.80 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.2% Upside | Upgrade to Pro+ | |
Almirall | Madrid | Healthcare | Pharmaceuticals | €1.89B | -49.5x | 0.2 | €8.84 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Faes Farma | Madrid | Healthcare | Pharmaceuticals | €1.15B | 11.8x | 1.59 | €3.68 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.7% Upside | Upgrade to Pro+ | |
Pharma Mar | Madrid | Healthcare | Pharmaceuticals | €845.73M | -485.8x | 4.35 | €48.16 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.2% Upside | Upgrade to Pro+ | |
Clinica Baviera | Madrid | Healthcare | Healthcare Providers & Services | €570.58M | 15x | 0.67 | €35 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Atrys Health | Madrid | Healthcare | Healthcare Providers & Services | €246.80M | -6.2x | -0.68 | €3.25 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Laboratorio Reig Jofre | Madrid | Healthcare | Pharmaceuticals | €222.57M | 23.1x | -11.25 | €2.78 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.1% Upside | Upgrade to Pro+ | |
Prim | Madrid | Healthcare | Healthcare Equipment & Supplies | €179.48M | 14.2x | 0.28 | €10.55 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oryzon Genomics | Madrid | Healthcare | Biotechnology & Medical Research | €116.57M | -30.7x | 10.77 | €1.85 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pangaea Oncology | Madrid | Healthcare | Biotechnology & Medical Research | €60.98M | -11.6x | 0.18 | €1.79 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotechnology Assets | Madrid | Healthcare | Biotechnology & Medical Research | €20.85M | 12x | 0.07 | €0.32 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Labiana Health | Madrid | Healthcare | Pharmaceuticals | €17.09M | -3.9x | €2.42 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.8% Downside | Upgrade to Pro+ | ||
Substrate Artificial Inteligence | Madrid | Healthcare | Healthcare Equipment & Supplies | €9.97M | -1x | -0.01 | €0.11 | -9.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Euroespes S.A. | Madrid | Healthcare | Healthcare Providers & Services | €3.67M | -3.2x | €0.34 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |